Latest Financial Results
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.
IR Contacts
Company
SCYNEXIS, Inc.
1 Evertrust Plaza
13th Floor
Jersey City, NJ 07302
T: (201) 884-5485
info@scynexis.com
Investor Relations
LifeSci Advisors
Irina Koffler
T: 646-970-4681
ikoffler@lifesciadvisors.com
Media
Ivor Macleod
Chief Financial Officer
Ivor.macleod@scynexis.com
Transfer Agent
American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449